Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C

van den Broek, Bryan; van der Flier, Michiel; van de Kar, Nicole C.A.J.; Wetzels, Jack F.M.; de Jonge, Marien I.; de Groot, Ronald; Wijnsma, Kioa L.; Langereis, Jeroen D.

doi:https://doi.org/10.1016/j.kint.2022.03.010

Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C

DSpace/Manakin Repository

Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C

van den Broek, Bryan; van der Flier, Michiel; van de Kar, Nicole C.A.J.; Wetzels, Jack F.M.; de Jonge, Marien I.; de Groot, Ronald; Wijnsma, Kioa L.; Langereis, Jeroen D.

(2022) Kidney International, volume 101, issue 6, pp. 1293 - 1295

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Nephrology

DOI: https://doi.org/10.1016/j.kint.2022.03.010

ISSN: 0085-2538

Publisher: Nature Publishing Group

(Peer reviewed)